(Q33374722)

English

A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit